Newsletter | September 10, 2026

09.10.26 -- Is Your Fill/Finish Strategy Ready To Scale?

 

Annex 1: Ensuring Sterile Pharmaceutical Manufacturing Standards

 

Adhering to the rigorous standards set by the EMA's Annex 1 requires strategic, risk-based compliance for facility design and processes, all of which is key to patient safety and future innovation.

 

The Strategic Benefits Of Isolator Lines In Manufacturing

Discover how high-speed isolator lines enable sterile, scalable manufacturing for complex biologics and injectables with unmatched efficiency and product integrity.

 

VIDEO FEATURE

Expertise In Commercial Fill/Finish For More Than 30 Years

Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.

 

SOLUTIONS

Fill/Finish Solutions That Grow With Your Program

Moving from clinical to commercial manufacturing? Learn how flexible fill-finish solutions, scalable capacity, and integrated support can help drive efficiency and readiness.

 

Introducing Our New High-Speed Isolator Filling Line

High-speed fill-finish integrates automation, isolators, and scalable capacity to boost efficiency, protect product quality, and meet rising biologics demand from clinical through commercial. 

 

Proven Expertise And Customized End-To-End Solutions For Your Products

Bring biologics to market efficiently with integrated development, large-scale manufacturing, rapid aseptic fill/finish, and trusted regulatory expertise.